12:00 AM
 | 
Sep 19, 2013
 |  BC Innovations  |  Distillery Therapeutics

Indication: Ophthalmic disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information
Ophthalmic disease
Diabetic retinopathy; diabetic macular edema (DME) Angiopoietin-like 4 (ANGPTL4)

Read the full 179 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$18 USD
More Info >